Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Common Equity (2021 - 2023)

Updated

Nika Pharmaceuticals' Common Equity was -$17,316 in Q4 2023, compared with -$17,316 a year earlier.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Common Equity (2021 - 2023) Analysis & Trends

From Q1 2021 onward, Nika Pharmaceuticals has reported Common Equity for 12 quarters.

  • In earlier years, Common Equity was -$17,316 in FY2022 and -$23,619 in FY2021.
  • Quarterly Common Equity has moved between -$74,835 (Q3 2023) and $4,073 (Q2 2022) over five years.
  • Per Business Quant data, NIKA's Common Equity in the three quarters before Q4 2023 was -$74,835 (Q3 2023), -$64,692 (Q2 2023) and -$36,886 (Q1 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -17,316.00
Sep 30, 2023 -74,835.00
Jun 30, 2023 -64,692.00
Mar 31, 2023 -36,886.00
Dec 31, 2022 -17,316.00
Sep 30, 2022 -2,266.00
Jun 30, 2022 4,073.00
Mar 31, 2022 83.00
Dec 31, 2021 -23,619.00
Sep 30, 2021 -20,319.00
Jun 30, 2021 -17,620.00
Mar 31, 2021 -14,661.00
API Access

Nika Pharmaceuticals, Inc Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NIKA&period=max&api_key=YOUR_API_KEY